The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A mechanistic role for cardiac myocyte apoptosis in heart failure
Open accessAbstract
Heart failure is a common, lethal condition whose pathogenesis is poorly understood. Recent studies have identified low levels of myocyte apoptosis (80-250 myocytes per 10(5) nuclei) in failing human hearts. It remains unclear, however, whether this cell death is a coincidental finding, a protective process, or a causal component in pathogenesis. Using transgenic mice that express a conditionally active caspase exclusively in the myocardium, we demonstrate that very low levels of myocyte apoptosis (23 myocytes per 10(5) nuclei, compared with 1.5 myocytes per 10(5) nuclei in controls) are sufficient to cause a lethal, dilated cardiomyopathy. Interestingly, these levels are four- to tenfold lower than those observed in failing human hearts. Conversely, inhibition of cardiac myocyte death in this murine model largely prevents the development of cardiac dilation and contractile dysfunction, the hallmarks of heart failure. To our knowledge, these data provide the first direct evidence that myocyte apoptosis may be a causal mechanism of heart failure, and they suggest that inhibition of this cell death process may constitute the basis for novel therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, inhibiting caspases can both reduce the occurrence of heart failure or slow its progression after MI (45, 131, 374, 383, 384) as well as improve contractile function (45).”
From Cardiac remodeling in obesity (2008) · cites this paper as [374]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
Apoptosis in Myocytes in End-Stage Heart Failure
Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., & Khaw, B.-A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351603 · Cited by 1,430
Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C. G., McDowell, J., Paskind, M. P., Rodman, L., Salfeld, J. G., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90490-5 · Cited by 1,408
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme
Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., et al. (1997) · Science · doi:10.1126/science.275.5297.206 · Cited by 1,159
An Induced Proximity Model for Caspase-8 Activation
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2926 · Cited by 1,023
Caspase activation: The induced-proximity model
Salvesen, G. S., & Dixit, V. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.10964 · Cited by 932
Controlling Signal Transduction with Synthetic Ligands
Spencer, D. M., Wandless, T. J., Schreiber, S. L., & Crabtree, G. R. (1993) · Science · doi:10.1126/science.7694365 · Cited by 845
Luo, W., Grupp, I. L., Harrer, J. M., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.3.401 · Cited by 706
Research works printed but not linked: 2
- Walter, 1989, Biotechniques., 7, 1065
- Li, 1997, Am. J. Physiol., 272, H2313
Cited by
Sorted by citations
Items 501–600 of 765
Ma, X., Zhang, Q., Zhu, H., Huang, K., Pang, W., & Zhang, Q. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021201 · Cited by 15
Asparagine Synthetase Marks a Distinct Dependency Threshold for Cardiomyocyte Dedifferentiation
Zhu, Y., Ackers-Johnson, M. A., Shanmugam, M. K., Pakkiri, L. S., Drum, C. L., Chen, Y., Kim, J., Paltzer, W. G., Mahmoud, A. I., Tan, W. L. W., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.063965 · Cited by 16
Zhu, J., Zhang, W., Yang, H., Wang, X., Zheng, Y., Zhang, Q., & Zhi, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080709 · Cited by 15
Prolonged cardiac NR4A2 activation causes dilated cardiomyopathy in mice
Ashraf, S., Taegtmeyer, H., & Harmancey, R. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00942-7 · Cited by 16
Tacar, O., Indumathy, S., Tan, M. L., Baindur‐Hudson, S., Friedhuber, A. M., & Dass, C. R. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12324 · Cited by 15
Ding, J., Chen, Y. X., Chen, Y., Mou, Y., Sun, X. T., Dai, D., Zhao, C. Z., Yang, J., Hu, S., & Guo, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15533 · Cited by 15
ANNEXIN V DETECTION OF LIPOPOLYSACCHARIDE-INDUCED CARDIAC APOPTOSIS
Petillot, P., Lahorte, C., Bonanno, E., Signore, A., Lancel, S., Marchetti, P., Vallet, B., Slegers, G., & Nevière, R. (2006) · Shock · doi:10.1097/01.shk.0000235085.56100.38 · Cited by 15
The protective effects of exercise and phosphoinositide 3-kinase (p110α) in the failing heart
Owen, K., Pretorius, L., & McMullen, J. R. (2009) · Clinical Science · doi:10.1042/cs20080183 · Cited by 15
Bott-Flügel, L., Weig, H.-J., Knödler, M., Städele, C., Moretti, A., Laugwitz, K., & Seyfarth, M. (2005) · Journal of molecular medicine · doi:10.1007/s00109-005-0683-z · Cited by 15
Grégoire, D., & Kmita, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-60327-292-6_25 · Cited by 16
Kang, J. H., Lee, H.-S., Park, D., Kang, Y.-W., Kim, S.-M., Gong, J., & Cho, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-00086-y · Cited by 14
Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair
He, X., Liang, J., Paul, C., Huang, W. C., Dutta, S., & Wang, Y. (2022) · Cells · doi:10.3390/cells11233914 · Cited by 15
Polymorphisms of presenilin-1 gene associate with dilated cardiomyopathy susceptibility
Li, H., Chen, Y., Zhou, B., Peng, Y., Sheng, F., & Rao, L. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0916-0 · Cited by 13
Gesing, A., Masternak, M. M., Lewiñski, A., Karbownik‐Lewińska, M., Kopchick, J. J., & Bartke, A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls231 · Cited by 14
Prescimone, T., Lionetti, V., Caselli, C., Aquaro, G. D., Cabiati, M., Ottaviano, V., Ry, S. D., & Giannessi, D. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.09.006 · Cited by 14
Pucci, A., Zanini, C., Granata, R., Ghignone, R., Iavarone, A., Broglio, F., Sorrentino, P., Bergamasco, L., Rinaldi, M., & Ghigo, E. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.12.022 · Cited by 14
Ono, M., Sunagawa, Y., Mochizuki, S., Katagiri, T., Takai, H., Iwashimizu, S., Inai, K., Funamoto, M., Shimizu, K., Shimizu, S., et al. (2022) · Cancers · doi:10.3390/cancers14030683 · Cited by 13
Expression of Endoplasmic Reticulum Chaperones in Cardiac Development
Papp, S., Zhang, X., Szabo, E., Michalak, M., & Opas, M. (2008) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192400802010031 · Cited by 13
Kita, T., Ogawa, M., Sato, H., Kasai, K., Tanaka, T., & Tanaka, N. (2007) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2007.00561.x · Cited by 13
Cardiac effects of renal ischemia
Dominguez, J. H., Xie, D., & Kelly, K. J. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00183.2022 · Cited by 13
Veliotes, D. G. A., Norton, G. R., Correia, R. J., Strijdom, H., Badenhorst, D., Brooksbank, R. L., & Woodiwiss, A. J. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181e92a01 · Cited by 13
Harada, M., Hojo, M., Kamiya, K., Kadomatsu, K., Murohara, T., Kodama, I., & Horiba, M. (2014) · Heart and Vessels · doi:10.1007/s00380-014-0569-5 · Cited by 13
Caspase-1 transcripts in failing human heart after mechanical unloading
Prescimone, T., D’Amico, A., Caselli, C., Cabiati, M., Viglione, F., Caruso, R., Verde, A., Ry, S. D., Trivella, M. G., & Giannessi, D. (2014) · Cardiovascular Pathology · doi:10.1016/j.carpath.2014.08.002 · Cited by 13
Liu, J., Fu, H., Chang, F., Wang, J., Zhang, S., Caudle, Y., Zhao, J., & Yin, D. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1231-8 · Cited by 14
Silencing calreticulin gene might protect cardiomyocytes from angiotensin II-induced apoptosis
Zhang, W., Liu, Z., Zhang, Y., Bao, Q., Wu, W., Huang, H., & Liu, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.02.020 · Cited by 13
Protective role and mechanism of snakegourd peel against myocardial infarction in rats.
Yang, G.-L., Min, D.-Y., Yan, J.-W., Yang, M., & Lin, G. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.03.014 · Cited by 11
Breast Cancer and the Role of Exercise in Women
Reigle, B. S., & Wonders, K. Y. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-492-0_7 · Cited by 13
Expression-targeted gene therapy for the treatment of transitional cell carcinoma
Zhang, X., Atala, A., & Godbey, W. T. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.7 · Cited by 13
Liu, Q., Huang, J., Ding, H., Tao, Y., Nan, J., Xiao, C., Wang, Y., Wu, R., Ni, C., Zhong, Z., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci177077 · Cited by 13
Mechanistic Role of Thioredoxin 2 in Heart Failure.
Chen, C.-F., Chen, H., Zhou, H., Ji, W.-D., & Min, W. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-55330-6_14 · Cited by 11
Zankov, D. P., Sato, A., Shimizu, A., & Ogita, H. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0394 · Cited by 12
Qin, Z., Gao, L., Lin, G., Zhu, H., Chen, Y., Zhong, F., Zhou, H., Duan, S., & Pu, J. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.01.006 · Cited by 12
Pathophysiology of heart failure and an overview of therapies
Ranek, M. J., Berthiaume, J. M., Kirk, J. A., Lyon, R. C., Sheikh, F., Jensen, B. C., Hoit, B. D., BUTANY, J. W., Tolend, M., Rao, V. A., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822224-9.00025-6 · Cited by 14
Feng, Q. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706130 · Cited by 12
Zahiruddin, Q. S., Agho, K., Gaidhane, S., Gaidhane, A. M., Gode, D., Kawalkar, U. G., Khatib, M. N., Raut, Y., Saxena, D. B., Simkhada, P. P., et al. (2014) · Annals of Tropical Medicine and Public Health · doi:10.4103/1755-6783.145008 · Cited by 12
In vivo detection of programmed cell death during mouse heart development
Lagunas, K. M., Yamaguchi, Y., Becker, C., Geisen, C., DeRuiter, M. C., Miura, M., Fleischmann, B. K., & Hesse, M. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0426-2 · Cited by 11
Iwahana, T., Okada, S., Kanda, M., Oshima, M., Iwama, A., Matsumiya, G., & Kobayashi, Y. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01396-2 · Cited by 12
Li, H., Niu, N., Yang, J., Dong, F., Zhang, T., Li, S., & Zhao, W. (2021) · Cell Biology International · doi:10.1002/cbin.11619 · Cited by 12
Characterization of human septic sera induced gene expression modulation in human myocytes.
Hussein, S., Michael, P., Brabant, D., Omri, A., Narain, R., Passi, K., Ramana, C. V., Parrillo, J. E., Kumar, A., Parissenti, A. M., et al. (2009) · PubMed Central · Cited by 12
ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart
Li, Y., Takemura, G., Okada, H., Miyata, S., Kanamori, H., Maruyama, R., Esaki, M., Li, L., Ogino, A., Ohno, T., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00361.2006 · Cited by 12
Aldosterone and cardiovascular remodelling: focus on myocardial failure
Shieh, F. K., Kotlyar, E., & Sam, F. (2004) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2004.005 · Cited by 12
Xiao, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.10.013 · Cited by 12
Zhang, Z.-H., Zhang, Z., Chen, M.-W., Yang, Y. N., Li, R.-J., Xu, J.-J., Yang, C. B., Li, Y.-Y., Chen, H.-W., Liu, S., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1115749 · Cited by 11
Long non-coding RNAs in the pathogenesis of heart failure: A literature review
Fan, X., Zhang, Z., Zheng, L., Wei, W., & Chen, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.950284 · Cited by 10
Belik, D. M., Bernasconi, R., Xu, L., Verde, G. D., Lorenz, V., Grüterich, V., Balzarolo, M., Mochizuki, M., Pfister, O., & Kuster, G. M. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01911-8 · Cited by 11
Xu, J., Lü, X.-W., Huang, Y., Zhu, P., & Li, J. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp/61.04.0013 · Cited by 11
Ins and outs of apoptosis in cardiovascular diseases.
Russo, G. L., & Russo, M. E. (2003) · NMCD. Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80034-0 · Cited by 13
Nanomedicine: A great boon for cardiac regenerative medicine
Choudhury, P., Kandula, N., Kosuru, R., & Adena, S. K. R. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176969 · Cited by 10
Liu, H., Guo, X., Yang, J., Xia, C., Yao, Y., Xiao, L., Liu, X., Yang, J., Li, X., Xu, Y., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02591 · Cited by 10
Oskuye, Z. Z., Mehri, K., Khalilpour, J., Nemati, S., Hosseini, L., Bafadam, S., Abdollahzade, N., & Badalzadeh, R. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101629 · Cited by 11
Liu, X., Wan, N., Zhang, X., Zhao, Y., Zhang, Y., Hu, G., Wan, F., Zhang, R., Zhu, X., Xia, H., et al. (2015) · Clinical Science · doi:10.1042/cs20140648 · Cited by 10
Cardiac apoptosis caused by elevated cholesterol level in experimental autoimmune myocarditis
Chang, H., Wang, Y., Wu, Y., Ma, P., Song, Y., Liu, C., Ye, Y., Qi, J., & Qi, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112169 · Cited by 10
Adverse effects of fetal exposure of electronic-cigarettes and high-fat diet on male neonatal hearts
Hasan, K. M., Munoz, A., Tumoyan, H., Parveen, M., Espinoza‐Derout, J., Shao, X. M., Mahata, S. K., Friedman, T. C., & Sinha‐Hikim, A. P. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104573 · Cited by 10
Weaver, J., McGregor, C. G. A., Tazelaar, H. D., & Badley, A. D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.05.017 · Cited by 10
Fertin, M. J., Bauters, A., Pinet, F., & Bauters, C. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.03.001 · Cited by 10
Vagus Nerve Stimulation for the Treatment of Heart Failure
Asad, Z. U. A., & Stavrakis, S. (2019) · Bioelectronics in Medicine · doi:10.2217/bem-2019-0012 · Cited by 10
Regulatory mechanisms of m6A methylation in dilated cardiomyopathy
Zhang, H. (2025) · American Journal of Translational Research · doi:10.62347/aosk8903 · Cited by 10
KLHL38 facilitates staurosporine‐induced apoptosis in HL‐1 cells via myocardin degradation
Luo, Y., Tian, L., Liang, C., & Xu, Y. (2022) · IUBMB Life · doi:10.1002/iub.2602 · Cited by 9
Apoptosis and long non-coding RNAs: Focus on their roles in Heart diseases
Al‐Masri, A. A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154889 · Cited by 9
Gao, M. H., Lai, N. C., Giamouridis, D., Kim, Y. C., Guo, T., & Hammond, H. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181282 · Cited by 9
CaMKII-δ9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart Failure
Zhang, M., Zhang, J., Zhang, W., Hu, Q., Li, J., Xie, P., Zheng, W., Shang, H., & Zhang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.820416 · Cited by 9
Reactive Oxygen Species (ROS) Signaling in Cardiac Remodeling and Failure
Harvey, A., & Grieve, D. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_50 · Cited by 9
Activation of MTK1/MEKK4 induces cardiomyocyte death and heart failure
Mizote, I., Yamaguchi, O., Hikoso, S., Takeda, T., Taneike, M., Oka, T., Tamai, T., Oyabu, J., Matsumura, Y., Nishida, K., et al. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.10.010 · Cited by 9
Surgery for Myocardial Salvage in Acute Myocardial Infarction and Acute Coronary Syndromes
Comas, G. M., Esrig, B. C., & Öz, M. C. (2007) · Heart Failure Clinics · doi:10.1016/j.hfc.2007.04.006 · Cited by 9
Pathophysiology of Heart Failure and an Overview of Therapies
Berthiaume, J. M., Kirk, J. A., Ranek, M. J., Lyon, R. C., Sheikh, F., Jensen, B. C., Hoit, B. D., BUTANY, J. W., Tolend, M., Rao, V. A., et al. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420219-1.00008-2 · Cited by 12
Oxidative Stress and Heart Failure
Chen, Q. M., Morrissy, S. J., & Alpert, J. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65249-2 · Cited by 9
Gottlieb, R. A. (2005) · Circulation Research · doi:10.1161/01.res.0000169466.84402.c1 · Cited by 9
Rao, Z., Tang, Y., Zhu, J., Lu, Z., Chen, Z., Wang, J., Bao, Y., Mukondiwa, A. V., Wang, C., Wang, X., et al. (2025) · Nanomaterials · doi:10.3390/nano15050346 · Cited by 8
Dilated cardiomyopathy: from genes and molecules to potential treatments
Wang, X., Lang, Z., Yan, Z., Xu, J., Zhang, J., Jiao, L., & Zhang, H. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05269-0 · Cited by 8
Qin, D., Jia, X. F., Hanna, A., Lee, J., Pekson, R., Elrod, J. W., Calvert, J. W., Frangogiannis, N. G., & Kitsis, R. N. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.09.004 · Cited by 9
Self-citationJiang, S., Han, S., & Wang, D. W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1358256 · Cited by 8
Functional tricuspid regurgitation and the right ventricle: what we do not know is more than we know
Calafiore, A. M., Bartoloni, G., Amri, H. A., Iaco, A. L., Abukhudair, W., Lanzaro, B. I., & Mauro, M. D. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.114 · Cited by 8
Cell Death in Cardiovascular Disease
Bennett, M. R. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.239954 · Cited by 8
Katz, J. N., & Drazner, M. H. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.03.046 · Cited by 8
Zhu, H., Li, M., Wu, J., Yan, L., Xiong, W., Hu, X., Lu, Z., Li, C., & Cai, H. (2024) · PeerJ · doi:10.7717/peerj.18591 · Cited by 7
Molecular imaging targets of cardiac remodeling
Shirani, J., & Dilsizian, V. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0022-z · Cited by 7
Self-citationZuwała−Jagiełło, J., Murawska‐Ciałowicz, E., & Pazgan−Simon, M. (2015) · BioMed Research International · doi:10.1155/2015/786570 · Cited by 7
Schauer, A., Barthel, P., Adams, V., Linke, A., Poitz, D. M., & Weinbrenner, C. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000969 · Cited by 7
Peng, H., Xu, J., Yang, X.-P., Kassem, K. M., Rhaleb, I. A., Peterson, E., & Rhaleb, N. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0047 · Cited by 8
Apoptosis in health, disease, and therapy: overview and methodology
LaCasse, E. C., Holčı́k, M., Korneluk, R. G., & MacKenzie, A. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511663543.002 · Cited by 7
Physiological versus pathological cardiac hypertrophy
McMullen, J. R., Sadoshima, J., & Izumo, S. (2005) · CRC Press eBooks · doi:10.3109/9780203503249-10 · Cited by 7
Apoptosis as a therapeutic target in heart failure
Das, M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00701.2007 · Cited by 7
Mitochondrial Dysfunction in Congenital Heart Disease
Silva, J. P. D., de Vito, M. C., Miyano, C. A., & Sucharov, C. C. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12020042 · Cited by 9
Xing, Y., Tian, T., Zhang, X., Yang, D., Zhang, C., Wang, M., Wang, Y., Luo, T., Wang, Z., Wang, H., et al. (2024) · Shock · doi:10.1097/shk.0000000000002354 · Cited by 6
Yang, S.-A., & Su, M. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-85 · Cited by 6
MiR-31a-5p protects myocardial cells against apoptosis by targeting Tp53
Yan, M., Tian, Z., Zhao, Z., & Yang, P. C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8357 · Cited by 6
Booth, S. A., Wadley, G. D., Marques, F. Z., Wlodek, M. E., & Charchar, F. J. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00042.2018 · Cited by 6
Apoptosis in Endomyocardial Biopsies from Patients with Dilated Cardiomyopathy
Glumac, S., Pejić, S., Kostadinović, S., Stojšić, Z., & Vasiljević, J. (2016) · Folia Biologica · doi:10.14712/fb2016062050207 · Cited by 6
Cardiomyocyte apoptosis in the ischemic and failing heart
Patten, R., & Karas, R. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.018 · Cited by 7
Clinical characteristics relevant to myocardial cell apoptosis: analysis of pericardial fluid
Doi, K. (2004) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1016/j.icvts.2004.01.019 · Cited by 6
Xu, J., Lü, X.-W., Huang, Y., Zhu, P., & Li, J. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.04.0013 · Cited by 6
Apoptosis in Cardiac Conditions Including Cirrhotic Cardiomyopathy
Yu, F., Ryu, D. G., Yoon, K. T., Liu, H., & Lee, S. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136423 · Cited by 5
Xu, Z., Meng, F., Yang, H., Liu, Y.-L., Ye, K.-Q., Qin, F., Liu, D., & Dai, H. (2025) · Biology · doi:10.3390/biology15010081 · Cited by 5
The atypical E3 ligase HOIL-1 safeguards the ribosome during cellular stress
Douglas, T., Nie, P., Zhang, J., Abdallah, K., Wu, Z., McReynolds, M. G., Iwaï, K., Peng, J., Gilbert, W. V., Young, L. H., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01936-6 · Cited by 6
Exploring the Cardiovascular Protective Effects of Baicalin: A Pathway to New Therapeutic Insights
Singh, S. K. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266347503241008075106 · Cited by 5
Exosomal non-coding RNAs: key regulators of inflammation-related cardiovascular disorders
Saadh, M. J., Muhammad, F. A., Albadr, R. J., Sanghvi, G. V., Ballal, S., Pathak, P. K., Bareja, L., Aminov, Z., Taher, W. M., Alwan, M., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-02649-6 · Cited by 5
CircRNA Interference Pathway: A New Target for Intervention in Different Stages of Heart Failure
Wang, Y., Chen, Q., Zhang, J., Deng, Y., Liu, C., Wang, S., Guo, M., & Song, L. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266300535240514104107 · Cited by 5
Tanoorsaz, S., Behpoor, N., & Tadıbı, V. (2018) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
Myocyte deficiency as a target in the treatment of cardiomyopathy
Rodrigues, C. O., Shehadeh, L. A., Webster, K. A., & Bishopric, N. H. (2007) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2007.05.001 · Cited by 5
Bogazzi, F., Russo, D., Raggi, F., Bohlooly‐Y, M., Törnell, J., Sardella, C., Lombardi, M., Urbani, C., Manetti, L., Brogioni, S., et al. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0402 · Cited by 5
Metadata
- Authors
- Wencker, D., Chandra, M., Nguyen, K., Miao, W., Garantziotis, S., Factor, S. M., Shirani, J., Armstrong, R. C., & Kitsis, R. N.
- Affiliations
- Albert Einstein College of Medicine (US)
- Yeshiva University (US)
- Pfizer (United States) (US)
- Corresponding author
- Kitsis, Richard N.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-05-15
- Volume
- 111
- Issue
- 10
- Pages
- 1497-1504
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC155051
- OpenAlex
- W2002958873
- Cited by
- 765
- References
- 29
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 27 · 2023: 18 · 2022: 31 · 2021: 18 · 2020: 31 · 2019: 23 · 2018: 28 · 2017: 32 · 2016: 35 · 2015: 28 · 2014: 45 · 2013: 30 · 2012: 42
- FWCI
- 32.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ariad Pharmaceuticals
- New York Academy of Medicine
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01-HL-61550, R01 HL-60665, R01HL061550, R01HL060665)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- cardiomyocyte apoptosis, heart failure, dilated cardiomyopathy, caspases, transgenic mice, myocardial cell death, contractile dysfunction, heart failure pathogenesis
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Heart Failure, Humans, Mice, Inbred C57BL, Mice, Transgenic, Myocardium, Organ Specificity, Recombinant Fusion Proteins, Tacrolimus, Apoptosis, Disease Progression, Transgenes, Dimerization, Caspases, Enzyme Activators, Tacrolimus Binding Proteins, Myocytes, Cardiac, Mice, Caspase 8, Caspase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review